• 287 Citations
  • 7 h-Index
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hironari Hanaoka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 287 Citations
  • 7 h-Index
  • 33 Article
  • 2 Review article
  • 1 Letter

A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus

Hanaoka, H., Nishimoto, T., Okazaki, Y., Takeuchi, T. & Kuwana, M., 2020 Apr 21, In : Arthritis Research and Therapy. 22, 1, 88.

Research output: Contribution to journalArticle

Open Access
  • High plasma mycophenolate acid concentration in the early phase of induction therapy predicts good renal outcome in lupus nephritis

    Kiyokawa, T., Hanaoka, H., Iida, H., Ishimori, K., Takakuwa, Y., Okazaki, T., Ozaki, S. & Kawahata, K., 2020 May 3, In : Modern rheumatology. 30, 3, p. 517-524 8 p.

    Research output: Contribution to journalArticle

  • Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse

    Takakuwa, Y., Hanaoka, H., Kiyokawa, T., Iida, H., Ishimori, K., Uekusa, T., Yamada, H. & Kawahata, K., 2019 Nov 1, In : Clinical and experimental rheumatology. 37, 6, p. 23-27 5 p.

    Research output: Contribution to journalArticle

  • A low perfusion-metabolic mismatch in 99mTl and 123I-BMIPP scintigraphy predicts poor prognosis in systemic sclerosis patients with asymptomatic cardiac involvement

    Iida, H., Hanaoka, H., Okada, Y., Kiyokawa, T., Takakuwa, Y., Yamada, H., Okazaki, T., Ozaki, S., Yamaguchi, K., Nakajima, Y. & Kawahata, K., 2019 Jan 1, In : International Journal of Rheumatic Diseases.

    Research output: Contribution to journalArticle

  • Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations

    Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y. & Kawahata, K., 2019 Oct 1, In : Clinical Rheumatology. 38, 10, p. 2785-2791 7 p.

    Research output: Contribution to journalArticle